These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clearance of antibody and complement in serum after challenge of mice previously vaccinated or infected with influenza virus. Semkow R, Wilczyński J. Acta Virol; 1979 May; 23(3):253-6. PubMed ID: 41439 [Abstract] [Full Text] [Related]
7. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D, Christopher ME, Nagata LP, Zabielski MA, Li H, Wong JP, Samuel J. J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [Abstract] [Full Text] [Related]
10. Immune responses to influenza virus in rabbits after local immunization. II. Local and systemic cell mediated response. Kasturi K, Hannoun C. Ann Microbiol (Paris); 1977 Apr; 128A(3):349-64. PubMed ID: 921142 [Abstract] [Full Text] [Related]
11. [Effect of regulator cells induced by the influenza virus in adoptive transfer]. Volgarev AP, Maĭorova LP, Smorodintsev AA. Biull Eksp Biol Med; 1987 Jan; 103(1):83-6. PubMed ID: 2879578 [Abstract] [Full Text] [Related]
12. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, Murphy BR. J Immunol; 1993 Jun 15; 150(12):5484-93. PubMed ID: 8390536 [Abstract] [Full Text] [Related]
17. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J. Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689 [Abstract] [Full Text] [Related]
18. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. Droebner K, Haasbach E, Fuchs C, Weinzierl AO, Stevanovic S, Büttner M, Planz O. Vaccine; 2008 Dec 09; 26(52):6965-74. PubMed ID: 18848593 [Abstract] [Full Text] [Related]
19. [Sensitization to the influenza virus in a combined experimental infection]. Gönczi S. Biull Eksp Biol Med; 1987 May 09; 103(5):603-6. PubMed ID: 3496128 [Abstract] [Full Text] [Related]
20. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies. Semenkov VF, Levina LV, Lavrov VF, Ageeva ON. Acta Virol; 1990 Feb 09; 34(1):37-43. PubMed ID: 1975723 [Abstract] [Full Text] [Related] Page: [Next] [New Search]